Impact of Nintedanib on tumor angiogenesis and vascular normalization in a mouse model of colorectal cancer
Abstract Background For many solid types of cancer including colorectal cancer treatment with the VEGF antibody bevacizumab as anti-angiogenic treatment has become standard of care. Nevertheless, long-term treatment with anti-angiogenic drugs in combination with other treatment modalities or alone c...
Saved in:
| Main Authors: | Naita M. Wirsik, Jens M. Seeger, Thomas Schmidt, Frank Hilberg, Hans F. Fuchs, Christiane J. Bruns, Oliver Coutelle, Hamid Kashkar, Lars M. Schiffmann |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-07-01
|
| Series: | Discover Oncology |
| Online Access: | https://doi.org/10.1007/s12672-025-03071-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The AP-1 factor JUNB correlates with poor survival of patients with esophageal adenocarcinoma
by: Nikolai Schleussner, et al.
Published: (2025-07-01) -
The impact of postoperative atrial fibrillation on complications and mortality following Ivor Lewis esophagectomy for esophageal cancer
by: Saeed Torabi, et al.
Published: (2025-07-01) -
Can Pirfenidone and Nintedanib Be Alternative Treatment Options for Radiation Pneumonitis?
by: Hikmet COBAN, et al.
Published: (2025-06-01) -
Therapeutic efficacy of pirfenidone and nintedanib in pulmonary fibrosis; a systematic review and meta-analysis
by: Yiting Qiu, et al.
Published: (2025-07-01) -
Vascular Basement Membrane Components in Angiogenesis — An Act of Balance
by: Lars Jakobsson, et al.
Published: (2008-01-01)